Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Mobile ad giants AppLovin and Unity locked in legal dispute over data collection
AppLovin seeks court order against Unity claiming improper collection of data generated through its business.
The Rundown: Average CMO tenure has shrunk by over a third in 16 years
Client-side turnover is increasing, according to a survey of 13,000 U.S. marketing professionals, and marketers are spending less time in post.
Behind Hoka’s bid to own the NYC marathon’s run-up period
Hoka’s been targeting runners training for the New York City marathon with the aim of creating more shoe evangelists.